Physician profile
Ryan M Slechta
NPI 1346461183
$334.38
in general payments reported to CMS, 2019-2025
13 companies · $25.01 in 2025
The $25.01 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.78 · 2021: $78.59 · 2022: $9.70 · 2023: $121 · 2025: $25.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $146.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $87.32 | 2021-2023 | |
| Bioventus LLC | $58.03 | 2019-2023 | Durolane |
| Stryker Corporation | $30.96 | 2023 | 1688 |
| Medtronic, INC. | $25.01 | 2025 | Aquamantys(Tm) |
| Pacira Pharmaceuticals Incorporated | $22.54 | 2023 | Iovera, Zilretta, Exparel |
| Hydrofera LLC | $19.45 | 2021 | |
| Smith+Nephew, INC. | $19.18 | 2019 | |
| Abbott Laboratories | $18.23 | 2021 | |
| Djo, LLC | $14.54 | 2019 | |
| Endo Pharmaceuticals INC. | $13.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.18 | 2019 | |
| Heraeus Medical, LLC. | $9.70 | 2022 | |
| Kinex Medical Company LLC | $4.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Slechta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.